Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.04 USD | +3.32% | +25.39% | +7.00% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.00% | 1.67B | |
+73.39% | 12.41B | |
-19.93% | 8.14B | |
+1.57% | 7.2B | |
+3.66% | 5.93B | |
+11.89% | 5.43B | |
+37.45% | 4.89B | |
-19.82% | 4.09B | |
-35.58% | 2.49B | |
+0.74% | 2.04B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Evercore ISI Adjusts Price Target on NovoCure to $15 From $14, Keeps In Line Rating